BNP Paribas’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.3M Buy
44,551
+30
+0.1% +$6.99K 0.31% 61
2026
Q1
$10.9M Buy
44,521
+2,365
+6% +$551K 0.35% 58
2025
Q4
$8.73M Buy
42,156
+26,286
+166% +$5.2M 0.25% 71
2025
Q3
$2.94M Buy
15,870
+1,165
+8% +$200K 0.09% 104
2025
Q2
$2.25M Sell
14,705
-340
-2% -$52.3K 0.07% 127
2025
Q1
$2.5M Sell
15,045
-5,223
-26% -$817K 0.1% 112
2024
Q4
$2.92M Buy
20,268
+4,182
+26% +$648K 0.02% 102
2024
Q3
$2.61M Sell
16,086
-194
-1% -$30.9K 0.11% 92
2024
Q2
$2.38M Sell
16,280
-6,161
-27% -$916K 0.12% 96
2024
Q1
$3.55M Buy
+22,441
New +$3.57M 0.17% 83

Other funds holding JNJ

BNP Paribas's JNJ Position: Q2 2026 in Review

BNP Paribas increased its Johnson & Johnson (JNJ) stake by 0.07% in Q2 2026, buying an estimated $6.99K and bringing the position to 44,551 shares worth $11.3M. The position accounts for 0.31% of the portfolio, ranked #61.

BNP Paribas first reported a position in JNJ in Q1 2024 and has held it in 10 quarters since. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • BNP Paribas held 44,551 shares of Johnson & Johnson worth $11.3M as of Q2 2026.
  • BNP Paribas bought 30 Johnson & Johnson shares in Q2 2026, an estimated $6.99K.
  • Johnson & Johnson made up 0.31% of BNP Paribas's portfolio in Q2 2026, its #61 holding.
  • BNP Paribas first reported a position in Johnson & Johnson in Q1 2024 and has held it in 10 quarters since.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on BNP Paribas's 13F filing for Q2 2026, filed 13 Aug 2026.